Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Gordon

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Investigative Dermatology|September 19, 2016
A Proteome-Derived Longitudinal Pharmacodynamic Biomarker for Diffuse Systemic Sclerosis SkinLisa M Rice, Julio C Mantero, Giuseppina Stifano, et al.
The Journal of Investigative Dermatology|August 16, 2017
Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82Robert Lafyatis, Julio C Mantero, Jessica Gordon, et al.
Rheumatology (Oxford, England)|November 19, 2013
Cardiac arrhythmias and conduction defects in systemic sclerosisAlessandra Vacca, Christophe Meune, Jessica Gordon, et al.
Plants (Basel, Switzerland)|June 2, 2021
Sulfur Deprivation Modulates Salicylic Acid Responses via Nonexpressor of Pathogenesis-Related Gene 1 in <i>Arabidopsis thaliana</i>Steven Criollo-Arteaga, Sofia Moya-Jimenez, Martin Jimenez-Meza, et al.
Journal of the American Chemical Society|September 2, 2025
Overcoming Immune Checkpoint Inhibitor Resistance with Potent, Selective Dual αvβ6/8 Inhibitors Based on Engineered Lasso PeptidesAnna Lechner, Peter A Jordan, Gabriella Costa Machado da Cruz, et al.
Journal of Scleroderma and Related Disorders|January 8, 2025
Patient perspectives on educational needs in scleroderma-interstitial lung diseaseTina M Savvaides, Thomas A Di Vitantonio, Armani Edgar, et al.
Seminars in Arthritis and Rheumatism|September 8, 2020
Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosisAntonia Valenzuela, Murray Baron, Tatiana S Rodriguez-Reyna, et al.
Nature Chemical Biology|September 11, 2024
Substrate interactions guide cyclase engineering and lasso peptide diversificationSusanna E Barrett, Song Yin, Peter Jordan, et al.
Journal of Medical Case Reports|June 10, 2015
Cardiac metabolomics and autopsy in a patient with early diffuse systemic sclerosis presenting with dyspnea: a case reportTracy M Frech, Monica P Revelo, John J Ryan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2020
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic SclerosisRobert Spiera, Laura Hummers, Lorinda Chung, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Investigative Dermatology|September 19, 2016
A Proteome-Derived Longitudinal Pharmacodynamic Biomarker for Diffuse Systemic Sclerosis SkinLisa M Rice, Julio C Mantero, Giuseppina Stifano, et al.
The Journal of Investigative Dermatology|August 16, 2017
Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82Robert Lafyatis, Julio C Mantero, Jessica Gordon, et al.
Rheumatology (Oxford, England)|November 19, 2013
Cardiac arrhythmias and conduction defects in systemic sclerosisAlessandra Vacca, Christophe Meune, Jessica Gordon, et al.
Plants (Basel, Switzerland)|June 2, 2021
Sulfur Deprivation Modulates Salicylic Acid Responses via Nonexpressor of Pathogenesis-Related Gene 1 in <i>Arabidopsis thaliana</i>Steven Criollo-Arteaga, Sofia Moya-Jimenez, Martin Jimenez-Meza, et al.
Journal of the American Chemical Society|September 2, 2025
Overcoming Immune Checkpoint Inhibitor Resistance with Potent, Selective Dual αvβ6/8 Inhibitors Based on Engineered Lasso PeptidesAnna Lechner, Peter A Jordan, Gabriella Costa Machado da Cruz, et al.
Journal of Scleroderma and Related Disorders|January 8, 2025
Patient perspectives on educational needs in scleroderma-interstitial lung diseaseTina M Savvaides, Thomas A Di Vitantonio, Armani Edgar, et al.
Seminars in Arthritis and Rheumatism|September 8, 2020
Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosisAntonia Valenzuela, Murray Baron, Tatiana S Rodriguez-Reyna, et al.
Nature Chemical Biology|September 11, 2024
Substrate interactions guide cyclase engineering and lasso peptide diversificationSusanna E Barrett, Song Yin, Peter Jordan, et al.
Journal of Medical Case Reports|June 10, 2015
Cardiac metabolomics and autopsy in a patient with early diffuse systemic sclerosis presenting with dyspnea: a case reportTracy M Frech, Monica P Revelo, John J Ryan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2020
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic SclerosisRobert Spiera, Laura Hummers, Lorinda Chung, et al.
Pageof 4